We serve Chemical Name:(2S)-2-amino-2-(2-methylphenyl)acetic acid CAS:339274-33-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(2S)-2-amino-2-(2-methylphenyl)acetic acid
CAS.NO:339274-33-8
Synonyms:(2S)-2-amino-2-(2-methylphenyl)acetic acid
Molecular Formula:C9H11NO2
Molecular Weight:165.18900
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:307.6ºC at 760 mmHg
Density:1.2g/cm3
Index of Refraction:1.579
PSA:63.32000
Exact Mass:165.07900
LogP:1.77970
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (2S)-2-amino-2-(2-methylphenyl)acetic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(2S)-2-amino-2-(2-methylphenyl)acetic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2S)-2-amino-2-(2-methylphenyl)acetic acid Use and application,(2S)-2-amino-2-(2-methylphenyl)acetic acid technical grade,usp/ep/jp grade.
Related News: In a memo to Branchburg employees on May 20, Nellie Clark, head of the plant, summed up the outside lawyers’ findings: “In the end and very importantly, allegations that Lilly made false statements to the FDA were not substantiated.” (2S)-2-amino-2-(2-methylphenyl)acetic acid manufacturer In approving the first new Alzheimer’s drug in nearly 20 years, the U.S. Food and Drug Administration is taking its biggest risk yet with a strategy that allows new therapies onto the market without strong evidence that they work, regulatory and scientific experts say. (2S)-2-amino-2-(2-methylphenyl)acetic acid supplier In a memo to Branchburg employees on May 20, Nellie Clark, head of the plant, summed up the outside lawyers’ findings: “In the end and very importantly, allegations that Lilly made false statements to the FDA were not substantiated.” (2S)-2-amino-2-(2-methylphenyl)acetic acid vendor In approving the first new Alzheimer’s drug in nearly 20 years, the U.S. Food and Drug Administration is taking its biggest risk yet with a strategy that allows new therapies onto the market without strong evidence that they work, regulatory and scientific experts say. (2S)-2-amino-2-(2-methylphenyl)acetic acid factory Inceptua has global operations with local offices across Europe, USA, and Asia
